211 related articles for article (PubMed ID: 9469342)
21. hTERT gene amplification and clinical significance in pleural effusions of patients with lung cancer.
Cha N; Li XY; Zhao YJ; Wang EH; Wu GP
Clin Lung Cancer; 2012 Nov; 13(6):494-9. PubMed ID: 22464057
[TBL] [Abstract][Full Text] [Related]
22. Clinical impact and reliability of carbonic anhydrase XII in the differentiation of malignant and tuberculous pleural effusions.
Liu YL; Jing LL; Guo QS
Asian Pac J Cancer Prev; 2013; 14(1):351-4. PubMed ID: 23534752
[TBL] [Abstract][Full Text] [Related]
23. [Pleural effusions--experience of Pneumo-phtisiology Hospital Tudor Vladimirescu--I: Clinical study].
Olaru M; Pleşea IE; Mălăescu D; Olaru R
Pneumologia; 2008; 57(3):138-46. PubMed ID: 18998326
[TBL] [Abstract][Full Text] [Related]
24. [Utility of polymerase chain reaction for diagnosis of tuberculous pleural effusion].
Hayashi M; Nagai A; Kobayashi K; Sawai T; Konno K
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Mar; 33(3):253-6. PubMed ID: 7739165
[TBL] [Abstract][Full Text] [Related]
25. Telomerase enzyme activity as a diagnostic tool to distinguish effusions of malignant and benign origin.
Spangler EA; Rogers KS; Thomas JS; Pustejovsky D; Boyd SL; Shippen DE
J Vet Intern Med; 2000; 14(2):146-50. PubMed ID: 10772485
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic value of lactate dehydrogenase isoenzyme pattern in pleural effusions.
Cobben NA; van Belle AF; Pennings HJ; Mulder PG; van Dieijen-Visser MP; Wouters EF; Drent M
Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):523-8. PubMed ID: 9263728
[TBL] [Abstract][Full Text] [Related]
27. Potential diagnostic value of methylation profile in pleural fluid and serum from cancer patients with pleural effusion.
Benlloch S; Galbis-Caravajal JM; Martín C; Sanchez-Paya J; Rodríguez-Paniagua JM; Romero S; Mafe JJ; Massutí B
Cancer; 2006 Oct; 107(8):1859-65. PubMed ID: 16983705
[TBL] [Abstract][Full Text] [Related]
28. Procalcitonin as a diagnostic marker in differentiating parapneumonic effusion from tuberculous pleurisy or malignant effusion.
Lee SH; Lee EJ; Min KH; Hur GY; Lee SY; Kim JH; Shin C; Shim JJ; In KH; Kang KH; Lee SY
Clin Biochem; 2013 Oct; 46(15):1484-8. PubMed ID: 23570862
[TBL] [Abstract][Full Text] [Related]
29. Pleural fluid cell-free DNA in parapneumonic pleural effusion.
Santotoribio JD; Cabrera-Alarcón JL; Batalha-Caetano P; Macher HC; Guerrero JM
Clin Biochem; 2015 Oct; 48(15):1003-5. PubMed ID: 26234638
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic value of pleural adenosine deaminase in tuberculous effusions of immunocompromised hosts.
Hsu WH; Chiang CD; Huang PL
J Formos Med Assoc; 1993 Jul; 92(7):668-70. PubMed ID: 7904507
[TBL] [Abstract][Full Text] [Related]
31. Cytological diagnosis and telomerase activity of cells in effusions of body cavities.
Toshima S; Arai T; Yasuda Y; Takaya T; Ito Y; Hayakawa K; Shibuya C; Yoshimi N; Shibayama M; Kashiki Y
Oncol Rep; 1999; 6(1):199-203. PubMed ID: 9864428
[TBL] [Abstract][Full Text] [Related]
32. In situ telomerase activity in pleural effusions: a promising marker for malignancy.
Dejmek A; Yahata N; Ohyashiki K; Ebihara Y; Kakihana M; Hirano T; Kawate N; Kato H
Diagn Cytopathol; 2001 Jan; 24(1):11-5. PubMed ID: 11135462
[TBL] [Abstract][Full Text] [Related]
33. Pleural fluid mesothelin as an adjunct to the diagnosis of pleural malignant mesothelioma.
Creaney J; Segal A; Olsen N; Dick IM; Musk AW; Skates SJ; Robinson BW
Dis Markers; 2014; 2014():413946. PubMed ID: 25505814
[TBL] [Abstract][Full Text] [Related]
34. Limited additive value of pleural fluid carcinoembryonic antigen level in malignant pleural effusion.
Riantawan P; Sangsayan P; Bangpattanasiri K; Rojanaraweewong P
Respiration; 2000; 67(1):24-9. PubMed ID: 10705258
[TBL] [Abstract][Full Text] [Related]
35. [The immunocytochemical study of pleural effusion and ascites using Ber-EP-4 antibodies].
Spehn J; Iwanetz S; Schmitz-Huebner U
Dtsch Med Wochenschr; 1995 Sep; 120(36):1197-200. PubMed ID: 7671771
[TBL] [Abstract][Full Text] [Related]
36. The diagnostic yield of pleural fluid cytology in malignant pleural effusions.
Ong KC; Indumathi V; Poh WT; Ong YY
Singapore Med J; 2000 Jan; 41(1):19-23. PubMed ID: 10783675
[TBL] [Abstract][Full Text] [Related]
37. The diagnostic significance of the detection of cytokeratin 19 mRNA by quantitative RT-PCR in benign and malignant pleural effusions.
Xu F; Chen J; Shen HH; Wang XD; Shan J
J Zhejiang Univ Sci; 2004 Oct; 5(10):1286-9. PubMed ID: 15362202
[TBL] [Abstract][Full Text] [Related]
38. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in diagnosis of pleural effusion of malignant origin.
Fiorelli A; Ricci S; Feola A; Mazzella A; D'Angelo L; Santini M; Di Domenico M; Di Carlo A
Interact Cardiovasc Thorac Surg; 2016 Apr; 22(4):411-8. PubMed ID: 26769731
[TBL] [Abstract][Full Text] [Related]
39. Pleural and serum markers for diagnosis of malignant pleural effusion.
Allama AM; Abou-Elela DH; Ibrahim IM
Asian Cardiovasc Thorac Ann; 2020 Nov; 28(9):560-565. PubMed ID: 32741198
[TBL] [Abstract][Full Text] [Related]
40. [Diagnostic significance of combining telomerase activity with CYFRA21-1 level in differentiating malignant pleural effusion caused by lung cancer from benign pleural effusion].
Li H; Fu J; Xiu Y; Zhou Q
Zhongguo Fei Ai Za Zhi; 2010 Jun; 13(6):652-4. PubMed ID: 20681457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]